Aditxt Inc
ADTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.93K
Close$
Share Statistics
| Market cap | $3,926.00 |
|---|---|
| Enterprise Value | $3.97 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1153.83 |
| Beta | 1.06 |
| Outstanding Shares | 20,174 |
Return
| Return on Equity | 129554.44% |
|---|---|
| Return on Assets | -310004.11% |
| Return on Invested Capital | -3462162.23% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | 0.0 |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 1.24 |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.07 |
| Debt to Equity | -0.13 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
June 3, 2026
EPS Estimate
$-224553600000.00
Average shareholder expectationRevenue Estimate
$1.00 M
Average shareholder expectationNext Earnings Call
Expected Date
September 2, 2026
EPS Estimate
$-24408000000.00
Average shareholder expectationRevenue Estimate
$1.00 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Aditxt Inc
43 employeesAditxt is developing technologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming. The immune monitoring technology is designed to provide a personalized comprehensive profile...